Panelists:
Tom Brennan
VP Nuclear Medicine
Marken
John Zehner
President and CEO
SpectronRx
- Time:
Radiopharmaceuticals have been on the market for decades, and in the era of personalized medicine, interest in them is growing because of their ability to treat patients with unprecedented accuracy. However, realizing their potential in clinical practice depends on overcoming a supply chain of unparalleled complexity, where precise timing is paramount. The challenge is immense: these life-saving therapies have a half-life measured in days, hours, or mere minutes. From the moment a dose is manufactured, the clock starts ticking, demanding a detailed logistical framework that operates with surgical precision.
In this GEN webinar, our expert speakers—Tom Brennan (VP Nuclear Medicine at Marken-UPS Healthcare Precision Logistics) and John Zehner (CEO/President of SpectronRx)—will describe the extraordinary journey of a radiopharmaceutical dose and explore the sophisticated dance of just-in-time manufacturing, real-time GPS and temperature tracking, and the intricate coordination required between production facilities, specialized couriers, and clinical teams. Viewers will gain a deeper understanding of the technology and operational expertise required to navigate the challenges of ultra-short shelf lives, ensuring these potent treatments reach patients exactly when needed to deliver the highest possible efficacy.
Key Takeaways:
- Understand why the ultra-short half-life of radiopharmaceuticals creates an unprecedented logistical challenge, making every minute from production to treatment critical.
- Get an inside look at the essential components for the supply chain, including advanced technology, innovation, and operational strategies coordinated to ensure on-time delivery.
- A clear appreciation for the orchestration required between stakeholders to make these therapies a reality for patients.
- The coordination and intricacies of both raw materials and patient-ready doses (PRDs).
A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.
Produced with support from:


